Clinical trials sponsored by Hangzhou Sciwind Biosciences Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Hangzhou Sciwind Biosciences Co., Ltd.

• A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
  NCT07243171 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
  NCT07734311 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
  NCT07387094 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Hangzhou Sciwind Biosciences Co., Ltd. recruiting for?

Hangzhou Sciwind Biosciences Co., Ltd. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.